Determination of the Absolute Oral Bioavailability of Niraparib by Simultaneous Administration of a 14c-Microtracer and Therapeutic Dose in Cancer Patients
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-017-3455-x
Full Text
Open PDFAbstract
Available in full text
Date
October 17, 2017
Authors
Publisher
Springer Science and Business Media LLC